This is a Phase 3b, open-label study to assess postoperative opioid use in subjects
undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of
HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be
conducted in 2 sequential parts: Part 1 is randomized and Part 2 is Investigator's preference
for MMA regimen.